{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:19:53Z","timestamp":1774923593489,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1212\/wnl.47.5.1227","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:24:15Z","timestamp":1336915455000},"page":"1227-1233","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":87,"title":["Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance"],"prefix":"10.1212","volume":"47","author":[{"given":"N.C.","family":"Notermans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"Lokhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Van der Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.L.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.G.I.","family":"Jennekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.H.","family":"Van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.J.","family":"Wokke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/117.1.1-a"},{"key":"e_1_3_1_3_2","first-page":"5","volume":"30","year":"1991","unstructured":"Gosselin S, Kyle R, Dyck P. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991;30:54-61.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_4_2","first-page":"9","volume":"117","year":"1994","unstructured":"Smith IS. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study. Brain 1994;117:949-957.","journal-title":"Brain"},{"key":"e_1_3_1_5_2","first-page":"1","volume":"43","year":"1993","unstructured":"Suarez GA, Kelly JJ. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 1993;43:1304-1308.","journal-title":"Neurology"},{"key":"e_1_3_1_6_2","first-page":"3","volume":"238","year":"1991","unstructured":"Yeung KB, Thomas PK, King RHM, et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. J Neurol 1991;238:383-391.","journal-title":"J Neurol"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410170103"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.1.1"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360104"},{"key":"e_1_3_1_10_2","first-page":"8","volume":"32","year":"1982","unstructured":"Abrams GM, Latov N, Hays AP, et al. Immunocytochemical studies of human peripheral nerve with serum from patients with polyneuropathy and paraproteinemia. Neurology 1982;32:821-826.","journal-title":"Neurology"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410180102"},{"key":"e_1_3_1_12_2","first-page":"5","volume":"33","year":"1993","unstructured":"Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated-glycoprotein. Ann Neurol 1993;33:502-506.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_13_2","first-page":"4","volume":"10","year":"1981","unstructured":"Dalakas MC, Engel W. Polyneuropathy with monoclonal gammopathy: studies of 11 patients. Ann Neurol 1981;10:45-52.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_14_2","first-page":"2","volume":"64","year":"1984","unstructured":"Meier C, Roberts K, Steck A, et al. Polyneuropathy in Waldenstrom's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis. Acta Neuropathol (Berl) 1984;64:297-307.","journal-title":"Acta Neuropathol (Berl)"},{"key":"e_1_3_1_15_2","first-page":"8","volume":"47","year":"1984","unstructured":"Sherman WH, Olarte MR, McKiernan G, et al. Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J Neurol Neurosurg Psychiatry 1984;47:813-819.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(86)90070-6"},{"key":"e_1_3_1_17_2","first-page":"1","volume":"45","year":"1988","unstructured":"Kelly JJ, Adelman LS, Berkamn E. Polyneuropathies associated with IgM monoclonal gammopathies. Arch Neurol 1988;45:1355-1359.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_18_2","first-page":"8","volume":"24","year":"1988","unstructured":"Haas DC, Tatum AH. Plasmapheresis alleviates neuropathy accompanying IgM anti-MAG paraproteinemia. Ann Neurol 1988;24:83-97.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_19_2","first-page":"8","volume":"24","year":"1988","unstructured":"Nobile-Orazio E, Baldini L, Barbieri S, et al. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol 1988;24:83-97.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_20_2","first-page":"2","volume":"40","year":"1990","unstructured":"Cook D, Dalakas M, Galdi A, et al. High dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 1990;40:212-214.","journal-title":"Neurology"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00582807"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107043250101"},{"key":"e_1_3_1_23_2","first-page":"4","volume":"15","year":"1992","unstructured":"Waterston JA, Brown MM, Ingram DA, Swash M. Cyclosporin, a therapy in paraprotein-associated neuropathy. Muscle Nerve 1992;15:445-448.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.1.1"},{"key":"e_1_3_1_25_2","first-page":"2","volume":"59","year":"1995","unstructured":"Oksenhendler E, Chrevet S, Leger JM, et al. Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J Neurol Neursurg Psychiatry 1995;59:243-247.","journal-title":"J Neurol Neursurg Psychiatry"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Latov NL. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 1995;37(S1):S32-S42.","DOI":"10.1002\/ana.410370705"},{"key":"e_1_3_1_27_2","first-page":"3","volume":"30","year":"1975","unstructured":"Roeser HP, Hocker GK, Kynaston B, et al. Advanced non-Hodgkin's lymphomas: response to treatment with combination chemotherapy and factors influencing prognosis. Br J Haematol 1975;30:323-327.","journal-title":"Br J Haematol"},{"key":"e_1_3_1_28_2","unstructured":"Notermans NC Wokke JHJ Jennekens FGI. Clinical work-up of the patient with a polyneuropathy. In: De Jong JMBV ed. Handbook of neurology. Amsterdam: Elsevier Science Publishers 1991:253-270."},{"key":"e_1_3_1_29_2","first-page":"2","volume":"57","year":"1994","unstructured":"Notermans NC, van Dijk GW, van der Graaf Y, van Gijn J, Wokke JHJ. Measuring ataxia: quantification based on the standard neurological examination. J Neurol Neurosurg Psychiatry 1994;57:22-26.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_30_2","first-page":"6","volume":"54","year":"1986","unstructured":"Halonen P. Quantitative vibration perception thresholds in healthy subjects of working age. Eur J Appl Physiol 1986;54:647-655.","journal-title":"Eur J Appl Physiol"},{"key":"e_1_3_1_31_2","first-page":"2","volume":"19","year":"1988","unstructured":"Van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for assessment of handicap in stroke patients. Stroke 1988;19:209-212.","journal-title":"Stroke"},{"key":"e_1_3_1_32_2","first-page":"5","volume":"17","year":"1994","unstructured":"Notermans NC, Franssen H, Wieneke G, Wokke JHJ. Temperature dependence of nerve conduction and EMG in neuropathy associated with gammopathy. Muscle Nerve 1994;17:516-522.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_33_2","first-page":"8","volume":"36","year":"1994","unstructured":"Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994;36:838-845.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_34_2","unstructured":"Shahani BT Young RR Potts F Maccabee P. Terminal latency index (TLI) and late response studies in motor neuron disease (MND) peripheral neuropathies and entrapment syndromes. Acta Neurol Scand 1979;Suppl 73:118."},{"key":"e_1_3_1_35_2","first-page":"9","volume":"117","year":"1994","unstructured":"Kaku DA, England JD, Summner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;117:941-947.","journal-title":"Brain"},{"key":"e_1_3_1_36_2","first-page":"6","volume":"41","year":"1991","unstructured":"Ad hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy CIDP. Neurology 1991;41:617-618.","journal-title":"Neurology"},{"key":"e_1_3_1_37_2","first-page":"4","volume":"42","year":"1992","unstructured":"Lange DJ, Trojaborg W, Latov N, et al. Multifocal motor neuropathy with conduction block: is it a distinct entity? Neurology 1992;42:497-505.","journal-title":"Multifocal motor neuropathy with conduction block: is it a distinct entity? Neurology"},{"key":"e_1_3_1_38_2","first-page":"2","volume":"25","year":"1990","unstructured":"Van den Berg LH, Sadiq SA, Thomas FP, Latov N. Characterization of HNK-1 bearing glycoprotein in human peripheral nerve myelin. J Neurosci Res 1990;25:295-299.","journal-title":"J Neurosci Res"},{"key":"e_1_3_1_39_2","first-page":"8","volume":"52","year":"1992","unstructured":"Van den Berg LH, Marrink J, De Jager AEJ, et al. Anti-GM1 antibodies in patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1992;52:8-11.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.1.1"},{"key":"e_1_3_1_41_2","first-page":"7","volume":"43","year":"1993","unstructured":"Nemni R, Fazio R, Quattrine A, et al. Antibodies to sulphatide and to chondroitin C in patients with chronic sensory neuropathy. J Neuroimmunol 1993;43:79-86.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_42_2","first-page":"2","volume":"47","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-211.","journal-title":"Cancer"},{"key":"e_1_3_1_43_2","first-page":"2","volume":"179","year":"1966","unstructured":"Axelsson U, Bachmann R, Hallen J. Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 1966;179:235-247.","journal-title":"Acta Med Scand"},{"key":"e_1_3_1_44_2","first-page":"7","volume":"40","year":"1972","unstructured":"Kyle RA, Finkelstein S, Elveback LR, Kurland LT. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 1972;40:719-724.","journal-title":"Blood"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.1.1"},{"key":"e_1_3_1_46_2","unstructured":"Kyle RA. Second malignancies associated with chemotherapy. In: Perry MC Yarbro JW eds. Toxicity of chemotherapy. New York: Grune & Stratton 1984;479-506."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.5.1227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:13:56Z","timestamp":1711534436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.5.1227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["10.1212\/WNL.47.5.1227"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.5.1227","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}